查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1950493

全球关节持续被动式锻炼器市场按类型、地区、最终用户和分销管道划分，2026-2032年预测

Joint Continuous Passive Motion Machine Market by Type, Target Area, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年协作式连续被动运动设备市场价值为 3.4548 亿美元，预计到 2026 年将成长至 3.7394 亿美元，年复合成长率为 8.72%，到 2032 年将达到 6.2037 亿美元。

关键市场统计数据
基准年 2025 3.4548亿美元
预计年份：2026年 3.7394亿美元
预测年份 2032 6.2037亿美元
复合年增长率 (%) 8.72%

权威的脉络化阐述了持续被动运动装置在现代復健中的临床意义、工作流程整合以及以病人为中心的益处

本导言旨在阐明理解关节持续被动运动（CPM）装置在现代治疗路径中不断演变的作用所需的临床、操作和技术背景。这些装置旨在促进解剖关节的受控被动运动，是復健治疗、术后通讯协定和家庭復健计画的交汇点。过去十年间，临床医生和装置研发人员携手合作，不断改进装置的人体工学设计、使用者介面和安全联锁装置，从而提高患者的舒适度，同时缩短监督治疗所需的时间。

全面探讨设备工程、数位连接和不断变化的护理服务模式如何重塑持续被动运动设备市场

设备设计、数位整合和护理模式创新的进步正在共同推动一场变革，重新定义人们对復健设备的期望。製造商正采用模组化设计和先进的运动控制技术，以适应不同的关节解剖结构和手术通讯协定，从而减少设置时间和临床医生的培训负担。同时，将感测器和连接功能引入持续被动运动（CPM）平台，可以客观地追踪关节活动范围，使临床医生能够制定个人化的治疗方案，并以更透明的方式报告治疗结果。

对近期关税变化对连续被动运动装置生态系统中零件采购、筹资策略和商业模式的影响进行分析评估

近期关税政策的累积影响，对进口商品和零件造成了衝击，给製造商、经销商和采购机构带来了新的营运考量。关税调整改变了致动器、控制电子元件和特殊塑胶等关键零件的到岸成本，促使采购团队重新审视供应商合约和整体拥有成本。为此，设备製造商正加快步伐，寻找替代供应商、实现关键零件的本地化生产，并重新设计组件，以减少对受关税影响零件的依赖。

详细的細項分析揭示了最终用户环境、解剖应用部位、设备配置和分销策略如何决定产品设计和商业化路径。

关键細項分析揭示了最终用户、应用场景、设备类型和分销管道等方面的细微动态特性，这些特征都会影响产品需求和商业性策略。按最终用户划分，市场涵盖诊所、居家照护、医院和復健中心。诊所进一步细分为门诊诊所和復健诊所，医院则分为私人医院和公立医院。这种细分錶明，门诊復健环境优先考虑紧凑的外形尺寸和快速安装，而住院和医院环境则重视与临床工作流程的整合以及由医护人员管理的安全功能。居家照护环境需要直觉的介面、清晰的安全连锁装置和远端监控功能，以支援独立使用或看护者辅助使用。

从区域比较观点，阐述了不同主要区域的临床标准、管理体制和买家偏好如何影响其应用和商业化策略。

区域趋势对美洲、欧洲、中东和非洲以及亚太地区的临床应用、监管要求和商业性执行都有显着影响。在美洲，决策越来越注重跨学科医疗团队的协作和报销机制的协调，从而推动了对具有成熟功能和与临床系统无缝互通性的医疗器材的需求。能够简化大规模医疗系统和门诊网路采购流程的服务模式也备受青睐。

竞争对手洞察：模组化设计、临床合作和服务导向经营模式如何在医疗设备市场实现永续差异化

对主要企业的深入分析凸显了他们在产品开发、伙伴关係和服务差异化方面的策略方针，这些方针将影响他们的竞争地位。领先的医疗设备开发商正在投资模组化架构，以实现功能逐步升级，从而延长产品生命週期并简化维护。他们还优先考虑人性化的设计，以减少临床医生的设置时间并提高患者在家中使用时的依从性，并融入了快速安装支架、直观操作和清晰的用户反馈机制等功能。

为企业提供切实可行的策略和营运建议，以加速产品推广应用、增强供应链韧性并展现临床和商业性价值。

针对行业领导者的具体建议侧重于产品、商业和营运措施，以深化市场进入并增强营运韧性。首先，优先考虑模组化设计和可配置软体，以便在无需昂贵重新设计的情况下，实现针对门诊、住院和居家照护等不同应用场景的设备变体。这种方法可以降低製造复杂性，加快部署速度，同时满足多样化的临床需求。其次，投资于嵌入式感测器套件和可互通的数据平台，以提供客观的恢復指标，使临床医生能够制定个人化护理方案，并向支付者和采购委员会展示临床价值。

我们采用严谨的多源调查方法，结合专家访谈、技术审查和供应链分析，以确保结论是基于证据且可重复。

我们的调查方法结合了多方面的证据基础、系统性的专家参与和严谨的定性综合分析，以确保获得可靠且可操作的见解。主要资料来源包括对临床医生、采购经理、设备开发人员和復健专业人员的结构化访谈，以了解设备在实际应用中的表现、工作流程的限制以及推广应用的驱动因素。此外，我们也对设备规格、监管申报文件和临床指导文件进行技术审查，以检验功能需求和合规性预期。

简洁扼要的结论整合了决定连续被动运动 (CPM) 设备在不断发展的领域中能否成功的技术、商业性和营运要素。

总之，持续被动运动装置在现代復健体系中占据着至关重要的地位，它连接着临床通讯协定、患者体验和不断发展的医疗服务模式。装置工程和数位化整合技术的进步正在拓展治疗能力，同时也改变了采购需求和分销管道的动态。关税趋势和供应链波动带来了压力，但也奖励企业采用更具韧性的采购方式、模组化设计以及以服务为导向的商业模式。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 关节持续被动运动设备市场（按类型划分）

  • 双面
  • 片面

第九章 按目标区域分類的联合持续被动运动设备市场

  • 踝
  • 弯头
  • 膝盖
  • 肩膀

第十章 按最终用户分類的联合持续被动运动设备市场

  • 诊所
    • 门诊部
    • 復健诊所
  • 居家照护
  • 医院
    • 私立医院
    • 公立医院
  • 復健中心

第十一章 按分销管道分類的联合连续被动运动设备市场

  • 直销
  • 电子商务
    • 製造商官方网站
    • 网路药房
  • 零售
  • 第三方经销商
    • 授权经销商
    • 独立销售代理

第十二章 各地区联合持续被动运动设备市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 联合持续被动运动设备市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国联合持续被动运动设备市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

15. 美国联合持续被动运动设备市场

第十六章：中国关节持续被动运动设备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Biodex Medical Systems, Inc.
  • Bio-Med Inc.
  • Bio-Medical Orthopaedic Equipment Suppliers
  • Breg, Inc.
  • Capital Medical Corporation
  • Chinesport SpA
  • DePuy Synthes, Inc.
  • DeRoyal Industries, Inc.
  • DJO LLC
  • Furniss Corporation
  • HMS Medical Systems
  • Kinex Medical Company, LLC
  • Mediware Information Systems, Inc.
  • Medi-Care Solutions Ltd.
  • Medline Industries, Inc.
  • OPED GmbH & Co. KG
  • OrthoAgility Ltd.
  • OrthoRehab, Inc.
  • Rehab-Robotics Company Limited
  • Smith & Nephew plc
  • Stryker Corporation
  • Surgi-Care, Inc.
  • TheraMotion, LLC
  • Zimmer Biomet Holdings, Inc.
  • Ossur hf
Product Code: MRR-4F7A6D4FD89C

The Joint Continuous Passive Motion Machine Market was valued at USD 345.48 million in 2025 and is projected to grow to USD 373.94 million in 2026, with a CAGR of 8.72%, reaching USD 620.37 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 345.48 million
Estimated Year [2026] USD 373.94 million
Forecast Year [2032] USD 620.37 million
CAGR (%) 8.72%

An authoritative contextual framing that explains clinical relevance, workflow integration, and patient-centered benefits of continuous passive motion devices within modern rehabilitation

The introduction establishes the clinical, operational, and technological context necessary to understand the evolving role of joint continuous passive motion (CPM) devices within contemporary care pathways. These devices, designed to facilitate controlled passive movement of anatomical joints, sit at the intersection of rehabilitative therapy, postoperative protocols, and home-based recovery programs. Over the past decade, clinicians and device developers have collaborated to refine device ergonomics, user interfaces, and safety interlocks that improve patient comfort while reducing time required for supervised therapy sessions.

This section situates CPM machines within multidisciplinary care, highlighting how surgeons, physical therapists, and home health providers integrate these tools into individualized treatment plans. It outlines the common clinical indications that drive device adoption and emphasizes the patient-experience improvements that contribute to adherence. Furthermore, it discusses how regulatory expectations and reimbursement dynamics influence clinical adoption, shaping device requirements for safety documentation, traceability, and interoperability with electronic medical records.

As the healthcare ecosystem shifts toward value-based outcomes and patient-centered care, CPM devices are increasingly assessed not only for their biomechanical performance but also for their capacity to support rehabilitation workflows, reduce caregiver burden, and enable remote monitoring. The introduction closes by framing the remaining sections: technological shifts, tariff impacts, segmentation nuances, regional dynamics, competitive positioning, actionable recommendations, methodology, and closing considerations designed to guide executive decisions.

A comprehensive exploration of how device engineering, digital connectivity, and shifting care delivery models are reshaping the continuous passive motion device market

The landscape is undergoing transformative shifts driven by advances in device design, digital integration, and care delivery models that together are redefining expectations for rehabilitation devices. Device manufacturers are incorporating modular designs and refined kinematic control to accommodate a broader range of joint anatomies and surgical protocols, enabling faster setup and reducing training demands for clinicians. At the same time, the infusion of sensors and connectivity into CPM platforms allows objective tracking of range-of-motion metrics, which clinicians can use to personalize therapy and report outcomes more transparently.

Concurrently, care delivery is decentralizing as more post-acute and rehabilitative services migrate from inpatient settings to outpatient clinics and home environments. This shift elevates the importance of portability, user-friendly interfaces, and battery efficiency in device selection criteria. Payment models and clinical protocols are adapting accordingly, with an increased emphasis on devices that support remote monitoring and data export for tele-rehabilitation programs.

Moreover, supply chain resilience and strategic sourcing have become central to competitive differentiation. Manufacturers and distributors are reevaluating production footprints, supplier relationships, and component standardization to mitigate disruption risks and improve margins. Taken together, these transformative shifts are driving convergence between mechanical reliability, digital capability, and service-oriented business models, altering how stakeholders evaluate product value and long-term partnerships.

An analytical assessment of how recent tariff shifts are influencing component sourcing, procurement strategies, and commercial models across the continuous passive motion device ecosystem

The cumulative impact of recent tariff developments affecting imports and components has introduced new operational considerations for manufacturers, distributors, and procuring institutions. Tariff adjustments alter landed costs for key components such as actuators, control electronics, and specialized plastics, prompting procurement teams to reexamine vendor contracts and total cost of ownership. In response, device manufacturers have accelerated efforts to qualify alternative suppliers, localize critical component manufacturing, and redesign assemblies to reduce reliance on tariff-affected parts.

These changes have cascading implications for contract negotiations and inventory strategies. Healthcare providers and group purchasing organizations increasingly include tariff exposure clauses and flexible sourcing requirements in long-term agreements. As a consequence, manufacturers that can demonstrate supply-chain transparency, multi-sourcing strategies, and component traceability gain a competitive advantage in procurement discussions.

Additionally, tariff-driven cost pressures have increased the appeal of service-based models, including subscription and managed-equipment offerings that shift capital expenditures into predictable operating expenses. This commercial flexibility can mitigate short-term pricing volatility for healthcare systems while maintaining access to advanced functionality. Ultimately, the tariff landscape is prompting a recalibration of supplier relationships, product design choices, and commercial models as stakeholders prioritize resilience, cost predictability, and continuity of care.

Detailed segmentation analysis revealing how end-user environments, anatomical applications, device configurations, and channel strategies determine product design and commercialization paths

Key segmentation insights reveal nuanced behavior across end users, applications, device types, and distribution channels, each influencing product requirements and commercial approaches. Based on End User, the market is studied across Clinics, Home Care, Hospitals, and Rehabilitation Centers, with Clinics further examined across Outpatient Clinics and Rehabilitation Clinics, and Hospitals further differentiated into Private Hospitals and Public Hospitals. This granularity shows that outpatient rehabilitation environments prioritize compact form factors and rapid setup, while inpatient and hospital contexts emphasize integration with clinical workflows and staff-managed safety features. Home care settings demand intuitive interfaces, clear safety interlocks, and remote-monitoring capabilities to support independent or caregiver-assisted use.

Based on Application, the market is studied across Ankle, Elbow, Knee, and Shoulder, and these anatomical distinctions drive product geometry, motion profiles, and accessory requirements. Knee applications typically necessitate robust range-of-motion programming and higher torque capacity, whereas shoulder and elbow solutions emphasize multi-axis articulation and stabilizing supports. Ankle solutions balance compactness with precise dorsiflexion and plantarflexion control to address postoperative mobility and tendon rehabilitation.

Based on Type, the market is studied across Bilateral and Unilateral configurations, which affect device complexity, portability, and price-performance equations; bilateral solutions often require synchronized motion control and broader support systems, while unilateral devices favor simplicity and lower footprint for targeted therapy. Based on Distribution Channel, the market is studied across Direct Sales, E-commerce, Retail, and Third-Party Distributors, with E-commerce further divided into Manufacturer Websites and Online Pharmacies and Third-Party Distributors further subdivided into Authorized Distributors and Independent Distributors. Distribution choices reflect buyer preferences for service levels, procurement timelines, and warranty or training bundles, and they shape how manufacturers design channel-specific SKUs and aftersales programs.

Comparative regional perspective outlining how clinical standards, regulatory regimes, and buyer preferences in major global regions shape adoption and commercialization strategies

Regional dynamics materially influence clinical adoption, regulatory expectations, and commercial execution across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, decision-making often emphasizes integration with multidisciplinary care teams and reimbursement alignment, driving demand for devices that can deliver documented functional outcomes and seamless interoperability with clinical systems. This region also favors service models that simplify procurement for larger health systems and outpatient networks.

In Europe, Middle East & Africa, regulatory harmonization in parts of Europe and varying approval pathways across the broader EMEA region require manufacturers to maintain flexible regulatory affairs strategies and localized documentation. Public procurement frameworks and central tenders in several countries place a premium on proven safety records, lifecycle cost considerations, and supplier reliability. In the Middle East and Africa, channel partnerships and distributor expertise are particularly important to navigate local contracting, installation, and training requirements.

The Asia-Pacific region presents a mix of advanced-care urban centers and emerging markets with growing access to rehabilitative services. Here, manufacturers must balance high-end feature sets demanded by tertiary hospitals with cost-efficient, scalable solutions for smaller clinics and home-based care. Rapidly evolving telehealth regulations and increasing digital health adoption across Asia-Pacific also create opportunities for devices that embed remote monitoring and analytics. Across all regions, successful market approaches blend clinical evidence, adaptable commercial models, and local support infrastructures.

Competitive company insights revealing how modular engineering, clinical partnerships, and service-oriented business models create sustained differentiation in device markets

Insights into key companies highlight strategic approaches to product development, partnerships, and service differentiation that influence competitive positioning. Leading device developers are investing in modular architectures that allow for incremental feature upgrades, enabling longer product lifecycles and simplified maintenance. They are also prioritizing human-centered design to reduce setup time for clinicians and to improve adherence in home environments, incorporating features such as quick-mount brackets, intuitive controls, and clear user feedback loops.

Beyond hardware, successful companies are bundling data services and outcome reporting that support value-based care discussions with payers and hospital procurement teams. Strategic partnership activity includes collaborations with rehabilitation providers, orthopedics groups, and technology firms to expand clinical validation and integrate remote monitoring capabilities. In addition, companies that have developed resilient manufacturing footprints and diversified supplier networks demonstrate greater agility when responding to supply-chain disruptions or tariff-driven cost shifts.

Commercially, firms differentiate through tailored service offerings such as training programs, extended warranties, managed equipment services, and subscription pricing that align with institutional budgeting cycles. Firms that combine clinical evidence, strong post-sales support, and channel depth are best positioned to capture long-term institutional relationships and to support scalable rollouts across multi-site healthcare systems.

Practical strategic and operational recommendations that companies can implement to accelerate adoption, strengthen supply resilience, and demonstrate clinical and commercial value

Actionable recommendations for industry leaders focus on product, commercial, and operational levers that can be implemented to deepen market access and operational resilience. First, prioritize modular design and configurable software that enable device variants to be tailored to outpatient, inpatient, and home-care use cases without costly redesigns. This approach reduces manufacturing complexity and accelerates time to deployment while meeting diverse clinical needs. Second, invest in embedded sensor suites and interoperable data platforms that provide objective recovery metrics, enabling clinicians to personalize therapy and demonstrate clinical value to payers and procurement committees.

Third, broaden supply-chain strategies by qualifying secondary suppliers for critical components, exploring nearshoring options for subassemblies, and establishing inventory buffers for high-risk parts. Fourth, develop channel strategies that align with buyer segmentation: support direct sales relationships for large institutional accounts while scaling digital and distributor channels to reach home-care and smaller clinic segments. Fifth, expand service portfolios to include managed equipment offerings, outcome-driven warranties, and training packages that reduce institutional friction and support long-term adoption.

Finally, pursue clinical evidence generation through focused trials and real-world evidence initiatives that document functional outcomes and patient-reported improvements. Coupled with clear value propositions, these steps position companies to respond to procurement scrutiny, adapt to tariff and supply pressures, and accelerate adoption across care settings.

A rigorous multi-source research methodology combining expert interviews, technical reviews, and supply-chain analysis to support evidence-based conclusions and reproducibility

The research methodology combines a multi-source evidence base, structured expert engagement, and rigorous qualitative synthesis to ensure robust and actionable findings. Primary inputs include structured interviews with clinicians, procurement leaders, device developers, and rehabilitation specialists to capture real-world device performance, workflow constraints, and adoption drivers. These engagements are complemented by technical reviews of device specifications, regulatory filings, and clinical guidance documents to validate feature requirements and compliance expectations.

Secondary inputs comprise an analysis of industry publications, white papers, and peer-reviewed clinical literature that document therapeutic outcomes associated with passive motion therapies and relevant device classes. Supply-chain assessments leverage customs and trade records, component sourcing data, and supplier disclosures to map dependencies and tariff exposure. Competitive landscaping relies on product literature, patents, and public filings to clarify technological differentiation and product road maps.

Data synthesis follows a transparent process: thematic coding of qualitative interviews, cross-validation against secondary sources, and iterative review with subject-matter experts to reconcile conflicting evidence. The methodology emphasizes reproducibility and traceability by documenting data sources, interview protocols, and analytical assumptions, and by providing stakeholders with the opportunity to validate findings during peer review sessions.

A concise conclusion synthesizing technological, commercial, and operational imperatives that will determine success in the evolving continuous passive motion device landscape

In conclusion, continuous passive motion devices occupy a pivotal role in modern rehabilitation ecosystems by bridging clinical protocols, patient experience, and evolving care delivery models. Advances in device engineering and digital integration are expanding therapeutic capabilities while simultaneously changing procurement expectations and channel dynamics. Tariff developments and supply-chain volatility add pressure but also create incentives for resilient sourcing, modular design, and service-oriented commercial models.

Segmentation analysis underscores the importance of tailoring product features and go-to-market strategies to distinct end users, anatomical applications, device configurations, and distribution channels. Regional dynamics further necessitate flexible regulatory and commercial approaches to address diverse reimbursement landscapes and institutional procurement processes. Competitive insights indicate that companies combining robust clinical evidence, flexible service models, and strong post-sales support are best positioned to secure long-term institutional relationships.

Taken together, these findings suggest that the most successful strategies will integrate technical innovation with operational resilience, focused clinical validation, and channel-aligned commercial models. By emphasizing patient outcomes, demonstrable value, and supply-chain agility, stakeholders can better navigate current market complexities and capitalize on opportunities to improve rehabilitation care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Joint Continuous Passive Motion Machine Market, by Type

  • 8.1. Bilateral
  • 8.2. Unilateral

9. Joint Continuous Passive Motion Machine Market, by Target Area

  • 9.1. Ankle
  • 9.2. Elbow
  • 9.3. Knee
  • 9.4. Shoulder

10. Joint Continuous Passive Motion Machine Market, by End User

  • 10.1. Clinics
    • 10.1.1. Outpatient Clinics
    • 10.1.2. Rehabilitation Clinics
  • 10.2. Home Care
  • 10.3. Hospitals
    • 10.3.1. Private Hospitals
    • 10.3.2. Public Hospitals
  • 10.4. Rehabilitation Centers

11. Joint Continuous Passive Motion Machine Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. E-commerce
    • 11.2.1. Manufacturer Websites
    • 11.2.2. Online Pharmacies
  • 11.3. Retail
  • 11.4. Third-Party Distributors
    • 11.4.1. Authorized Distributors
    • 11.4.2. Independent Distributors

12. Joint Continuous Passive Motion Machine Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Joint Continuous Passive Motion Machine Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Joint Continuous Passive Motion Machine Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Joint Continuous Passive Motion Machine Market

16. China Joint Continuous Passive Motion Machine Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Biodex Medical Systems, Inc.
  • 17.6. Bio-Med Inc.
  • 17.7. Bio-Medical Orthopaedic Equipment Suppliers
  • 17.8. Breg, Inc.
  • 17.9. Capital Medical Corporation
  • 17.10. Chinesport S.p.A.
  • 17.11. DePuy Synthes, Inc.
  • 17.12. DeRoyal Industries, Inc.
  • 17.13. DJO LLC
  • 17.14. Furniss Corporation
  • 17.15. HMS Medical Systems
  • 17.16. Kinex Medical Company, LLC
  • 17.17. Mediware Information Systems, Inc.
  • 17.18. Medi-Care Solutions Ltd.
  • 17.19. Medline Industries, Inc.
  • 17.20. OPED GmbH & Co. KG
  • 17.21. OrthoAgility Ltd.
  • 17.22. OrthoRehab, Inc.
  • 17.23. Rehab-Robotics Company Limited
  • 17.24. Smith & Nephew plc
  • 17.25. Stryker Corporation
  • 17.26. Surgi-Care, Inc.
  • 17.27. TheraMotion, LLC
  • 17.28. Zimmer Biomet Holdings, Inc.
  • 17.29. Ossur hf

LIST OF FIGURES

  • FIGURE 1. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY BILATERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY BILATERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY BILATERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY UNILATERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY UNILATERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY UNILATERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY ANKLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY ANKLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY ANKLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY ELBOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY ELBOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY ELBOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY KNEE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY KNEE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY KNEE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY SHOULDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY SHOULDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY SHOULDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY REHABILITATION CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY REHABILITATION CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY REHABILITATION CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY MANUFACTURER WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY AUTHORIZED DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY AUTHORIZED DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY AUTHORIZED DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 159. GCC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GCC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. GCC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 162. GCC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. GCC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 164. GCC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 165. GCC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. GCC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 167. GCC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 186. G7 JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. G7 JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. G7 JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 189. G7 JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. G7 JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 191. G7 JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 192. G7 JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. G7 JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 194. G7 JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 195. NATO JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. NATO JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. NATO JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 198. NATO JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. NATO JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 200. NATO JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 201. NATO JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. NATO JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 203. NATO JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)